tiprankstipranks
Trending News
More News >
Immunovia AB (SE:IMMNOV)
:IMMNOV
Sweden Market
Advertisement

Immunovia AB (IMMNOV) Income Statement

Compare
2 Followers

Immunovia AB Income Statement

Last quarter (Q2 2025), Immunovia AB's total revenue was kr90.00K, an increase of 5.88% from the same quarter last year. In Q2, Immunovia AB's net income was kr-41.05M. See Immunovia AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 931.00Kkr 1.57Mkr 1.15Mkr 844.00Kkr 362.00K
Gross Profit
kr 931.00Kkr -5.11Mkr -3.07Mkr 15.81Mkr 40.38M
Operating Expenses
kr 110.34Mkr 291.35Mkr 188.14Mkr 182.55Mkr 175.06M
Depreciation and Amortization
kr 13.42Mkr 141.72Mkr 24.91Mkr 19.06Mkr 9.76M
EBITDA
kr -61.27Mkr -148.46Mkr -141.58Mkr -135.47Mkr -134.85M
Operating Income
kr -109.41Mkr -296.46Mkr -191.15Mkr -166.74Mkr -134.68M
Other Income/Expenses
kr 32.87Mkr -12.98Mkr 23.06Mkr 10.66Mkr -11.69M
Pretax Income
kr -76.54Mkr -309.44Mkr -168.09Mkr -155.97Mkr -146.03M
Net Income
kr -76.54Mkr -309.44Mkr -145.03Mkr -157.40Mkr -147.45M
Per Share Metrics
Basic EPS
kr -0.93kr -7.95kr -5.95kr -6.45kr -6.41
Diluted EPS
kr -0.93kr -7.95kr -5.95kr -6.45kr -6.41
Weighted Average Shares Outstanding
82.61M 38.93M 24.39M 24.39M 22.99M
Weighted Average Shares Outstanding (Diluted)
82.61M 38.93M 24.39M 24.39M 22.99M
Currency in SEK

Immunovia AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis